Certification of Human Immunoglobulin Standard Samples for Determination of Anticomplementary Activity
- Authors: Krivykh M.A.1, Kornilova O.G.1, Bunyatyan N.D.1, Paramonova E.V.1, Kudasheva É.Y.1, Novikova E.V.1, Ustinnikova O.B.1, Volkova R.A.1, Fadeikina O.V.1
-
Affiliations:
- Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
- Issue: Vol 50, No 12 (2017)
- Pages: 833-836
- Section: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244489
- DOI: https://doi.org/10.1007/s11094-017-1542-2
- ID: 244489
Cite item
Abstract
An evaluation and stability study of the original Russian human immunoglobulin standard intended for determining the anticomplementary activity and assessing the stability and acceptability of test results are reported. The certified values of the experimental anticomplementary activity of the negative control standard fell in the range 37.9 – 45.1%; of the positive control, 73.6 – 82.8% (for P = 0.95). Ashelf life of 1.5 years was justified based on the stability data of the standard sample. Introduction of the certified reference materials into the analysis of human immunoglobulin pharmaceutical preparation for intravenous administration during evaluation and quality control under government projects and confirmation of compliance with regulatory requirements will ensure that the determined anticomplementary properties are accurate.
About the authors
M. A. Krivykh
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
O. G. Kornilova
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
N. D. Bunyatyan
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
E. V. Paramonova
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
É. Yu. Kudasheva
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
E. V. Novikova
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
O. B. Ustinnikova
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
R. A. Volkova
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051
O. V. Fadeikina
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, Moscow, 127051